Search

Your search keyword '"Chan, Gary"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Chan, Gary" Remove constraint Author: "Chan, Gary" Publisher wiley Remove constraint Publisher: wiley
113 results on '"Chan, Gary"'

Search Results

3. Transitions to polysubstance use: Prospective cohort study of adolescents in Australia

4. Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis

6. A systematic review and meta‐analysis of the relationship between youth drinking, self‐posting of alcohol use and other social media engagement (2012–21)

8. Abrocitinib efficacy and safety in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study

11. Global prevalence of heated tobacco product use, 2015‐2022: a systematic review and meta‐analysis.

14. A latent class analysis of patterns of tobacco and cannabis use in Australia and their health‐related correlates

15. A wastewater‐based evaluation of the effectiveness of codeine control measures in Australia

23. Getting high for likes: Exploring cannabis‐related content on TikTok

26. The experience of physiological and psychosocial alcohol‐related harms across adolescence and its association with alcohol use disorder in early adulthood: A prospective cohort study

31. Content analysis of cannabis vaping videos on YouTube

32. Trajectories of alcohol‐induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood

36. Case of “relapsing” COVID ‐19 in a kidney transplant recipient

37. Telephone‐based motivational interviewing enhanced with individualised personality‐specific coping skills training for young people with alcohol‐related injuries and illnesses accessing emergency or rest/recovery services: a randomized controlled trial (QuikFix)

39. Letter: corticosteroid use alongside tofacitinib in OCTAVE Open. Authors' reply

41. Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

47. Long‐term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open‐label, 48‐week extension study

Catalog

Books, media, physical & digital resources